Neochem Bio Solutions Limited (NSE:NEOCHEM)

Neochem Bio Solutions Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	1,107	1,107	841.73	612.6	481.88	495.72
Revenue Growth	123.31%	31.51%	37.40%	27.13%	-2.79%	-
Gross Profit Gross Profit Growth	338.98	338.98	269.74	218.24	153.07	495.72
Operating Income Operating Income Growth	210.51	210.51	132.33	57.21	35.42	12.6
Net Income Net Income Growth	120.27	120.27	74.4	19.27	10.73	9.67
Earnings Per Share EPS Growth	8.71	8.71	11.15	2.89	2.03	-
EPS Growth	-	-21.86%	286.10%	42.36%	-	-

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	1,067	1,067	769.3	552.36	419.79	44,347
Export Export Growth	40.26	40.26	72.42	59.11	-	4,248
Total Total Growth	1,107	1,107	841.73	611.46	457.06	48,595

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	1.81	1.81	0.55	3.51	0.48	-
Total Debt Total Debt Growth	177.94	177.94	356.24	333.23	262.37	-
Net Cash (Debt) Net Cash Growth	-176.13	-176.13	-355.69	-329.72	-261.89	-
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-12.76	-12.76	-53.29	-49.40	-49.50	-

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-169.38	-169.38	20.36	-6.31	-7.42	-
Capital Expenditures CapEx Growth	-29.54	-29.54	-14.83	-83.85	-33.3	-
Free Cash Flow Free Cash Flow Growth	-198.92	-198.92	5.52	-90.16	-40.72	-
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	30.62%	30.62%	32.05%	35.63%	31.76%	100.00%
Operating Margin	19.02%	19.02%	15.72%	9.34%	7.35%	2.54%
Pretax Margin	15.52%	15.52%	11.82%	4.57%	3.15%	2.58%
Profit Margin	10.86%	10.86%	8.84%	3.15%	2.23%	1.95%
FCF Margin	-17.97%	-17.97%	0.66%	-14.72%	-8.45%	-

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	11.17	9.00	-	-	-	-
PS Ratio	1.50	0.98	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error